Credit Suisse’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-687
| Closed | -$27K | – | 3396 |
|
|
2020
Q4 | $27K | Buy |
+687
| New | +$27K | ﹤0.01% | 3431 |
|
|
2019
Q4 | – | Sell |
-1,180
| Closed | -$67K | – | 3462 |
|
|
2019
Q3 | $67K | Sell |
1,180
-138
| -10% | -$7.84K | ﹤0.01% | 3332 |
|
|
2019
Q2 | $157K | Buy |
1,318
+201
| +18% | +$23.9K | ﹤0.01% | 3246 |
|
|
2019
Q1 | $205K | Sell |
1,117
-374
| -25% | -$68.6K | ﹤0.01% | 3165 |
|
|
2018
Q4 | $265K | Buy |
1,491
+203
| +16% | +$36.1K | ﹤0.01% | 3036 |
|
|
2018
Q3 | $412K | Sell |
1,288
-157
| -11% | -$50.2K | ﹤0.01% | 2930 |
|
|
2018
Q2 | $579K | Buy |
1,445
+52
| +4% | +$20.8K | ﹤0.01% | 2901 |
|
|
2018
Q1 | $499K | Buy |
1,393
+59
| +4% | +$21.1K | ﹤0.01% | 2952 |
|
|
2017
Q4 | $529K | Buy |
1,334
+376
| +39% | +$149K | ﹤0.01% | 2923 |
|
|
2017
Q3 | $408K | Buy |
+958
| New | +$408K | ﹤0.01% | 3123 |
|
|
2016
Q3 | – | Sell |
-574
| Closed | -$33K | – | 3719 |
|
|
2016
Q2 | $33K | Buy |
+574
| New | +$33K | ﹤0.01% | 3860 |
|
|
2015
Q4 | – | Sell |
-513
| Closed | -$52K | – | 3962 |
|
|
2015
Q3 | $52K | Sell |
513
-1,801
| -78% | -$183K | ﹤0.01% | 3950 |
|
|
2015
Q2 | $293K | Buy |
+2,314
| New | +$293K | ﹤0.01% | 3743 |
|